Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
about
Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical applicationHepatobiliary MR imaging with gadolinium-based contrast agentsDescription of focal liver lesions with Gd-EOB-DTPA enhanced MRIA diagnostic paradigm for resectable liver lesions: to biopsy or not to biopsy?Detection of small hepatocellular carcinoma: comparison of dynamic enhancement magnetic resonance imaging and multiphase multirow-detector helical CT scanning.Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults.Comparison of CT and 18F-FDG pet for detecting peritoneal metastasis on the preoperative evaluation for gastric carcinomaMR-arterioportography: a new technical approach for detection of liver lesions.Systematic review of radiological imaging for hepatocellular carcinoma in cirrhotic patients.Comparison of dynamic gadolinium-enhanced and ferumoxides-enhanced MRI of the liver on high- and low-field scanners.Percentage of signal intensity loss for characterisation of focal liver lesions in patients with chronic liver disease using ferucarbotran-enhanced MRI.Diagnostic imaging of hepatocellular carcinoma in patients with cirrhosis before liver transplantation.Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media.Distinguishing benign from malignant liver tumours.SPIO-enhanced MRI findings of well-differentiated hepatocellular carcinomas: correlation with MDCT findingsDiagnostic accuracy of multi-/single-detector row CT and contrast-enhanced MRI in the detection of hepatocellular carcinomas meeting the milan criteria before liver transplantation.Detection of small hypervascular hepatocellular carcinomas in cirrhotic patients: comparison of superparamagnetic iron oxide-enhanced MR imaging with dual-phase spiral CT.Optimal pulse sequence for ferumoxides-enhanced MR imaging used in the detection of hepatocellular carcinoma: a comparative study using seven pulse sequences.Diagnostic accuracy of MR imaging to identify and characterize focal liver lesions: comparison between gadolinium and superparamagnetic iron oxide contrast media.[Radiological diagnosis of hepatic tumors. Part II: Identification and differential diagnosis].Detection of hepatocellular carcinoma by ferumoxides-enhanced MR imaging in cirrhosis: Incremental value of dynamic gadolinium-enhancement.MR imaging of hepatocellular carcinoma: relationship between lesion size and imaging findings, including signal intensity and dynamic enhancement patterns.Quantitative evaluation of 2-deoxy-2[F-18]fluoro-D-glucose-positron emission tomography imaging on the woodchuck model of hepatocellular carcinoma with histological correlation.MR characterisation of dysplastic nodules and hepatocarcinoma in the cirrhotic liver with hepatospecific superparamagnetic contrast agents: pathological correlation in explanted livers.Comparison of ferucarbotran-enhanced fluid-attenuated inversion-recovery echo-planar, T2-weighted turbo spin-echo, T2*-weighted gradient-echo, and diffusion-weighted echo-planar imaging for detection of malignant liver lesions.Superparamagnetic iron oxide (SPIO)-enhanced liver MRI with ferucarbotran: efficacy for characterization of focal liver lesions.Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: value of SPIO-enhanced MR imaging at 3.0 Tesla.Imaging well-differentiated hepatocellular carcinoma with dynamic triple-phase helical computed tomography.Multiple non-tumorous arterioportal shunts due to chronic liver disease mimicking hepatocellular carcinoma: outcomes and the associated elevation of alpha-fetoprotein.Nodule-in-nodule appearance of hepatocellular carcinomas: comparison of gadolinium-enhanced and ferumoxides-enhanced magnetic resonance imaging.Ferumoxide-enhanced MR imaging of hepatocellular carcinoma: correlation with histologic tumor grade and tumor vascularity.Small (<or=3 cm) hepatocellular carcinoma in cirrhosis: the role of double contrast agents in MR imaging vs. multidetector-row CTRecent advances in the diagnosis of hepatocellular carcinoma
P2860
Q24613744-EC268606-7BAA-4F5B-A1AF-80FF5E425BB8Q24631773-1D2B89B9-5C01-4E71-9E6F-01362BC41F9AQ26770825-BCD0D4CB-FA73-4886-8574-A9EF6C7B203AQ33585177-9AFDCDF5-92D4-4070-9D4C-7A23417C02ABQ34099585-6A10B2E3-1526-49BB-946D-CBC60A33D5FFQ34532749-947AFF75-A8A3-407B-A9E1-7AA19EF18CFBQ34572989-3902120B-90BD-425A-A3CA-44D250FF4D82Q34772055-B863E70D-BFD9-4554-BB1A-07B4E0F298C7Q35869746-74ABE587-6D59-4D8C-815E-D884689EC9FDQ35897368-F3E4C6F0-B1F6-412D-9E6A-EAD86EAF0CE4Q36324508-3376D95D-FB84-487A-86AE-DC390F268A7DQ36628332-8008F064-FBBF-4993-A877-6AAE9E086FAEQ36789118-68C3897D-8F59-4C2B-BE55-A8B77790C618Q36963716-0C9318E8-DAF6-442C-BF62-978A4A5D9292Q37118064-68A997EE-DAAA-415F-9D6C-5B2AAFEA9402Q37188267-5FBDB6B8-BC9D-495A-8960-647ED7592BB8Q37231625-DEB12CB5-CEE6-4D05-B512-DF0AD9E3F151Q37270092-3E84F45A-04CA-486E-BD82-8993AFC56524Q39920197-E762B141-EC2E-4FB0-AE60-2F317FE542C9Q45003154-D23A4F6D-BEE9-4B24-B1B4-858E916D95D0Q46134318-D3A6E792-59AC-44F7-B786-C88B2CF87E20Q47263779-110BDD72-0B56-446E-B478-6BFDD7761493Q51063932-968223C5-971E-44BD-9539-A750BCFAA97CQ53304862-6656D3DF-62C0-44BD-9C32-050625772DD2Q53307405-07B6E34B-EEF6-4540-885A-7A295DEA9AB1Q53496562-5EF8DBAB-8941-4520-9F23-F2C8C474DE56Q53518489-E85F2BFE-C671-4BFF-8C03-DFEEA942E479Q53540827-CBE3B3C4-CE55-4416-B23A-C8F8BCCF1C45Q53553056-F2312C5C-5490-4695-B0D9-7FCF18889A80Q53617096-05D56BE4-BC52-4A87-A72C-66CB1ACBB9ABQ53635339-4542793C-E476-48AE-BFC4-5D7232004A07Q56989774-F6ACCBF0-24D3-4956-B224-D7F2E8E2D45DQ56994598-302239BF-3806-4C13-A9E6-26E4099D05BF
P2860
Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Detection of hepatocellular ca ...... rumoxides-enhanced MR imaging.
@en
Detection of hepatocellular ca ...... rumoxides-enhanced MR imaging.
@nl
type
label
Detection of hepatocellular ca ...... rumoxides-enhanced MR imaging.
@en
Detection of hepatocellular ca ...... rumoxides-enhanced MR imaging.
@nl
prefLabel
Detection of hepatocellular ca ...... rumoxides-enhanced MR imaging.
@en
Detection of hepatocellular ca ...... rumoxides-enhanced MR imaging.
@nl
P2093
P1476
Detection of hepatocellular ca ...... rumoxides-enhanced MR imaging.
@en
P2093
K Katahira
K Mitsuzaki
M Takahashi
T Namimoto
Y Yamashita
P304
P356
10.2214/AJR.172.6.10350287
P407
P577
1999-06-01T00:00:00Z